Innospec, Inc. (IOSP) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156003,
    "name": "Innospec, Inc.",
    "stock_name": "Innospec, Inc.",
    "full_name": "Innospec, Inc.",
    "name_url": "stocks-analysis/innospec-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "74.01",
    "chg": -0.36,
    "chgp": "-0.48%",
    "dir": -1,
    "prev_price": "74.37",
    "mcapval": "2,534.06",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Chemicals & Petrochemicals",
    "ind_code": 2205,
    "indexname": "S&P 500",
    "isin": "US45768S1050",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "232.21 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/innospec-inc-1156003-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Innospec, Inc. Hits New 52-Week Low at $71.81 Amidst Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innospec-inc-hits-new-52-week-low-at-7181-amidst-decline-3671514",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnospecInc_priceRelatedfactors_3671514.png",
        "date": "2025-11-04 17:56:43",
        "description": "Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and low debt-to-equity ratio, but has struggled to match market benchmarks."
      },
      {
        "title": "Innospec, Inc. Hits 52-Week Low at USD 72.03 Amid Significant Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innospec-inc-hits-52-week-low-at-usd-7203-amid-significant-decline-3667313",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnospecInc_priceRelatedfactors_3667313.png",
        "date": "2025-11-03 17:11:55",
        "description": "Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and a conservative financial structure, but faces challenges in profitability and growth."
      },
      {
        "title": "Innospec, Inc. Experiences Revision in Stock Evaluation Amid Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innospecs-valuation-grade-downgraded-from-attractive-to-fair-amid-yearly-decline-3667059",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/InnospecInc_valuationdot_3667059.png",
        "date": "2025-11-03 15:44:01",
        "description": "Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its valuation metrics, including a P/E ratio of 14 and a notable dividend yield of 787.74%. Despite competitive financial indicators, the company has underperformed compared to the S&P 500, indicating market challenges."
      },
      {
        "title": "Innospec, Inc. Hits New 52-Week Low at USD 72.33",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innospec-inc-hits-new-52-week-low-at-usd-7233-3661981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InnospecInc_priceRelatedfactors_3661981.png",
        "date": "2025-10-31 16:19:31",
        "description": "Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and low debt-to-equity ratio, but has struggled to outperform market benchmarks."
      },
      {
        "title": "Innospec, Inc. Hits 52-Week Low at USD 72.74 Amid Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innospec-inc-hits-52-week-low-at-usd-7274-amid-declining-performance-3659167",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InnospecInc_priceRelatedfactors_3659167.png",
        "date": "2025-10-30 18:42:23",
        "description": "Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, shows a high dividend yield and a low debt-to-equity ratio, but has struggled with flat financial results and underperformance compared to the S&P 500."
      },
      {
        "title": "Is Innospec, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-innospec-inc-overvalued-or-undervalued-3651104",
        "imagepath": "",
        "date": "2025-10-28 11:13:06",
        "description": "As of 24 October 2025, the valuation grade for Innospec, Inc. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that the stock is reasonably priced relative to its earnings growth potential.\n\nIn comparison to its peers, Eastman Chemical Co. has a higher P/E ratio of 15.68, while Element Solutions, Inc. shows a significantly higher EV to EBITDA of 14.82, indicating that Innospec is competitively positioned within its industry. Notably, Innospec's stock has underperformed relative to the S&P 500, with a year-to-date return of -30.67% compared to the index's 15.47%, reinforcing the notion that the stock may be struggling to attract investor interest despite its fair valuation...."
      },
      {
        "title": "Innospec, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innospec-inc-sees-valuation-grade-downgrade-from-attractive-to-fair-3649015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/InnospecInc_valuationdot_3649015.png",
        "date": "2025-10-27 15:45:52",
        "description": "Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation metrics, showcasing a P/E ratio of 14 and a strong dividend yield of 787.74%. Despite recent performance challenges, its financial indicators suggest competitive positioning within the industry compared to peers."
      },
      {
        "title": "Is Innospec, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-innospec-inc-overvalued-or-undervalued-3647609",
        "imagepath": "",
        "date": "2025-10-27 11:13:12",
        "description": "As of 24 October 2025, the valuation grade for Innospec, Inc. moved from attractive to fair, indicating a shift in its market perception. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that while the company is generating reasonable earnings relative to its price, there may be more attractive opportunities in the market.\n\nInnospec's P/E ratio is lower than its peer Eastman Chemical Co., which has a P/E of 15.68, but higher than Ingevity Corp., which has a P/E of 11.75. The EV to EBITDA ratio of 10.31 is also competitive compared to peers, indicating that Innospec is valued reasonably within its industry. However, the company's recent stock performance has been underwhelming, with a year-to-date return of -30.67% compared to the S&P 500's positive return of 15.47%, highlighting a significan..."
      },
      {
        "title": "Is Innospec, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-innospec-inc-overvalued-or-undervalued-3646147",
        "imagepath": "",
        "date": "2025-10-26 11:09:43",
        "description": "As of 24 October 2025, the valuation grade for Innospec, Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that the stock is reasonably priced compared to its earnings growth potential.\n\nIn comparison to peers, Eastman Chemical Co. has a higher P/E of 15.68, while Element Solutions, Inc. shows a significantly higher EV to EBITDA at 14.82, indicating that Innospec may be more attractively priced relative to these competitors. Over the past year, Innospec has underperformed the S&P 500, with a return of -30.17% compared to the index's 16.90%, reinforcing the notion that the stock may be facing challenges despite its fair valuation...."
      }
    ],
    "total": 24,
    "sid": "1156003",
    "stock_news_url": "https://www.marketsmojo.com/news/innospec-inc-1156003"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Innospec, Inc. Hits New 52-Week Low at $71.81 Amidst Decline

2025-11-04 17:56:43

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and low debt-to-equity ratio, but has struggled to match market benchmarks.

Innospec, Inc. Hits 52-Week Low at USD 72.03 Amid Significant Decline

2025-11-03 17:11:55

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, has a high dividend yield and a conservative financial structure, but faces challenges in profitability and growth.

Innospec, Inc. Experiences Revision in Stock Evaluation Amid Competitive Market Landscape

2025-11-03 15:44:01

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has recently adjusted its valuation metrics, including a P/E ratio of 14 and a notable dividend yield of 787.74%. Despite competitive financial indicators, the company has underperformed compared to the S&P 500, indicating market challenges.

Innospec, Inc. Hits New 52-Week Low at USD 72.33

2025-10-31 16:19:31

Innospec, Inc. Hits 52-Week Low at USD 72.74 Amid Declining Performance

2025-10-30 18:42:23

Innospec, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of USD 2,534 million, shows a high dividend yield and a low debt-to-equity ratio, but has struggled with flat financial results and underperformance compared to the S&P 500.

Is Innospec, Inc. overvalued or undervalued?

2025-10-28 11:13:06

As of 24 October 2025, the valuation grade for Innospec, Inc. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that the stock is reasonably priced relative to its earnings growth potential. In comparison to its peers, Eastman Chemical Co. has a higher P/E ratio of 15.68, while Element Solutions, Inc. shows a significantly higher EV to EBITDA of 14.82, indicating that Innospec is competitively positioned within its industry. Notably, Innospec's stock has underperformed relative to the S&P 500, with a year-to-date return of -30.67% compared to the index's 15.47%, reinforcing the notion that the stock may be struggling to attract investor interest despite its fair valuation....

Innospec, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Metrics

2025-10-27 15:45:52

Innospec, Inc., a small-cap company in the Chemicals & Petrochemicals sector, has adjusted its valuation metrics, showcasing a P/E ratio of 14 and a strong dividend yield of 787.74%. Despite recent performance challenges, its financial indicators suggest competitive positioning within the industry compared to peers.

Is Innospec, Inc. overvalued or undervalued?

2025-10-27 11:13:12

As of 24 October 2025, the valuation grade for Innospec, Inc. moved from attractive to fair, indicating a shift in its market perception. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that while the company is generating reasonable earnings relative to its price, there may be more attractive opportunities in the market. Innospec's P/E ratio is lower than its peer Eastman Chemical Co., which has a P/E of 15.68, but higher than Ingevity Corp., which has a P/E of 11.75. The EV to EBITDA ratio of 10.31 is also competitive compared to peers, indicating that Innospec is valued reasonably within its industry. However, the company's recent stock performance has been underwhelming, with a year-to-date return of -30.67% compared to the S&P 500's positive return of 15.47%, highlighting a significan...

Is Innospec, Inc. overvalued or undervalued?

2025-10-26 11:09:43

As of 24 October 2025, the valuation grade for Innospec, Inc. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 14, an EV to EBITDA of 10.31, and a PEG ratio of 0.82, which suggest that the stock is reasonably priced compared to its earnings growth potential. In comparison to peers, Eastman Chemical Co. has a higher P/E of 15.68, while Element Solutions, Inc. shows a significantly higher EV to EBITDA at 14.82, indicating that Innospec may be more attractively priced relative to these competitors. Over the past year, Innospec has underperformed the S&P 500, with a return of -30.17% compared to the index's 16.90%, reinforcing the notion that the stock may be facing challenges despite its fair valuation....

View All News